Harrow Health, Inc.

NASDAQ:HROW

30.54 (USD) • At close June 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 199.614130.19388.59572.47648.87151.16541.37226.77419.9429.7161.660.010.10000000
Cost of Revenue 49.24539.6425.38318.21414.46316.74916.52113.5059.8315.2061.09300000.0010000.4
Gross Profit 150.36990.55363.21254.26234.40834.41624.85113.26910.1114.510.5670.010.1000000-0.4
Gross Profit Ratio 0.7530.6960.7130.7490.7040.6730.6010.4960.5070.4640.342110000000
Reseach & Development Expenses 12.236.6523.0511.0842.4132.0830.8250.4130.7390.3320.2371.6161.2990.1120.1952.9661.9911.8330.150
General & Administrative Expenses 000000017.9617.56912.5048.0875.9950000000.430
Selling & Marketing Expenses 00000007.0597.3826.4962.390.086000000-0.4240
SG&A 129.06483.0958.24341.31531.24733.09629.24325.01924.9511910.4776.0812.980.8282.3081.5981.7562.8590.0060.136
Other Expenses 0.2530.38-15.930.249-3.84.0890.10300.3030.03100000000-0.110
Operating Expenses 142.01690.12261.29352.39933.6639.21130.06825.43225.6919.33210.7147.6974.2790.9392.5034.5643.7462.8590.0460.136
Operating Income 8.8220.4311.9191.6140.385-4.795-5.217-12.163-15.882-14.822-10.147-7.687-4.179-0.939-2.503-4.564-3.746-2.859-0.046-0.536
Operating Income Ratio 0.0440.0030.0220.0220.008-0.094-0.126-0.454-0.796-1.526-6.112-768.688-41.7890000000
Total Other Income Expenses Net -26.864-24.141-15.93-19.488-3.84.67819.842-0.757-3.316-1.0770.0290.044-1.205-0.015-0.0290.010.375-1.425-0.534-0.003
Income Before Tax -18.042-23.71-14.011-17.874-3.415-0.11714.625-12.92-19.198-15.899-10.118-7.643-5.384-0.954-2.531-4.554-3.371-4.285-0.58-0.54
Income Before Tax Ratio -0.09-0.182-0.158-0.247-0.07-0.0020.353-0.483-0.963-1.636-6.094-764.312-53.8350000000
Income Tax Expense -161,0000.7010.0750.1330.0040.008-19.449-0.935-0.1111.077-0.029-0.0441.195-0.06-0.026-0.01-0.817-0.2280.010
Net Income -17.481-24.411-14.086-18.007-3.3570.16814.625-11.985-19.087-15.899-10.118-7.643-5.384-0.954-2.531-4.554-3.304-4.285-0.046-0.54
Net Income Ratio -0.088-0.187-0.159-0.248-0.0690.0030.353-0.448-0.957-1.636-6.094-764.312-53.8350000000
EPS -0.49-0.75-0.51-0.69-0.130.010.67-0.6-1.5-1.66-1.11-0.88-1.24-2.4-6.41-11.67-8.92-19.37-0.25-4.32
EPS Diluted -0.49-0.75-0.51-0.69-0.130.010.61-0.6-1.5-1.66-1.11-0.88-1.24-2.4-6.41-11.67-8.92-19.37-0.25-4.32
EBITDA 20.0039.954-3.1024.2593.4911.908-3.374-10.398-14.173-14.212-10.062-7.637-5.356-0.879-2.475-4.553-4.121-2.748-0.046-0.536
EBITDA Ratio 0.10.076-0.0350.0590.0710.037-0.082-0.388-0.711-1.463-6.061-763.747-53.5590000000